SCHEMBL7992936

SCHEMBL7992936

COC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@H](OC(C)=O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 0.79
▸ MAPT P10636 2/20 0.79
▸ MEN1 O00255 2/20 0.79
▸ KMT2A Q03164 2/20 0.79
▸ LMNA P02545 1/20 0.79
▸ MAPK1 P28482 1/20 0.79
▸ VDR P11473 2/20 0.65
▸ GPBAR1 Q8TDU6 7/20 0.63
▸ NR1H4 Q96RI1 2/20 0.63
▸ SLC10A2 Q12908 2/20 0.63
▸ TBXA2R P21731 1/20 0.63
▸ PDE3A Q14432 1/20 0.63
▸ CYP2C9 P11712 1/20 0.61
▸ HIF1A Q16665 1/20 0.61
▸ CYP3A4 P08684 2/20 0.59
▸ SLCO1B3 Q9NPD5 1/20 0.59
▸ SLCO1B1 Q9Y6L6 1/20 0.59
▸ ABCC4 O15439 1/20 0.56
▸ CA1 P00915 1/20 0.54
▸ CA2 P00918 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14315480 1.00 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA
SCHEMBL17578641 1.00 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA
SCHEMBL17578745 1.00 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA
SCHEMBL10073740 1.00 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA
SCHEMBL330008 1.00 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA
SCHEMBL12644541 1.00 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA
SCHEMBL17898400 1.00 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA
SCHEMBL12644507 0.95 USP2 (0.71) USP2MAPTMEN1KMT2ALMNA
SCHEMBL14570885 0.93 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA
SCHEMBL5030971 0.93 USP2 (0.79) USP2MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274118-B1 INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE NORDION INTERNATIONAL INC. (CA) 2001-08-14 — — US disclosed
WO-1995002424-A1 LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN NORDION INTERNATIONAL INC. (CA) 1995-01-26 — — WO disclosed
Send feedback